Author:
Davis N. F.,Burke J. P.,Redmond E. J.,Elamin S.,Brady C. M.,Flood H. D.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference18 articles.
1. Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P et al (2011) Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol 60:784–795
2. Kuo HC (2011) Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics. Neurourol Urodyn 30:1242–1248
3. Karsenty G, Baverstock R, Carlson K, Diaz DC, Cruz F et al (2014) Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure. Int J Clin Pract 68:731–742
4. Ju R, Garrett J, Wu JM (2014) Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States. Int Urogynecol J 25:479–484
5. Tubaro A (2004) Defining overactive bladder: epidemiology and burden of disease. Urology 64:2–6
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献